title: Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
abstract: Toll-like receptors (TLRs) are key components of the innate immune system that trigger antimicrobial host defense responses. The aim of the present study was to analyze the effects of probiotic Escherichia coli Nissle strain 1917 in experimental colitis induced in TLR-2 and TLR-4 knockout mice. Colitis was induced in wild-type (wt), TLR-2 knockout, and TLR-4 knockout mice via administration of 5% dextran sodium sulfate (DSS). Mice were treated with either 0.9% NaCl or 10(7) E. coli Nissle 1917 twice daily, followed by the determination of disease activity, mucosal damage, and cytokine secretion. wt and TLR-2 knockout mice exposed to DSS developed acute colitis, whereas TLR-4 knockout mice developed significantly less inflammation. In wt mice, but not TLR-2 or TLR-4 knockout mice, E. coli Nissle 1917 ameliorated colitis and decreased proinflammatory cytokine secretion. In TLR-2 knockout mice a selective reduction of gamma interferon secretion was observed after E. coli Nissle 1917 treatment. In TLR-4 knockout mice, cytokine secretion was almost undetectable and not modulated by E. coli Nissle 1917, indicating that TLR-4 knockout mice do not develop colitis similar to the wt mice. Coculture of E. coli Nissle 1917 and human T cells increased TLR-2 and TLR-4 protein expression in T cells and increased NF-kappaB activity via TLR-2 and TLR-4. In conclusion, our data provide evidence that E. coli Nissle 1917 ameliorates experimental induced colitis in mice via TLR-2- and TLR-4-dependent pathways.
authors.affiliation: Charité-Universitätsmedizin Berlin, Campus Virchow Clinic, Department of Hepatology and Gastroenterology, Augustenburger Platz 1, D-13353 Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Grabig
authors.forename: D
authors.initials: D
authors.lastname: Paclik
authors.forename: C
authors.initials: C
authors.lastname: Guzy
authors.forename: A
authors.initials: A
authors.lastname: Dankof
authors.forename: D C
authors.initials: DC
authors.lastname: Baumgart
authors.forename: J
authors.initials: J
authors.lastname: Erckenbrecht
authors.forename: B
authors.initials: B
authors.lastname: Raupach
authors.forename: U
authors.initials: U
authors.lastname: Sonnenborn
authors.forename: J
authors.initials: J
authors.lastname: Eckert
authors.forename: R R
authors.initials: RR
authors.lastname: Schumann
authors.forename: B
authors.initials: B
authors.lastname: Wiedenmann
authors.forename: A U
authors.initials: AU
authors.lastname: Dignass
authors.forename: A
authors.initials: A
authors.lastname: Sturm
mesh_terms: D000818:Animals; D002460:Cell Line; D003093:Colitis, Ulcerative / Q000276:immunology / Q000382:microbiology* / Q000517:prevention & control*; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000502:physiology*; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019936:Probiotics; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D051197:Toll-Like Receptor 4 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*
chemical_list: C493486:Tlr2 protein, mouse; C493487:Tlr4 protein, mouse; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4